Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection
Files
(Published version)
Date
2013
Authors
Lum, M.
Attridge, S.
Morona, R.
Editors
Mantis, N.J.
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
PLoS One, 2013; 8(12):e84975-1-e84975-17
Statement of Responsibility
Mabel Lum, Stephen R. Attridge and Renato Morona
Conference Name
Abstract
Shigella flexneri remains a significant human pathogen due to high morbidity among children < 5 years in developing countries. One of the key features of Shigella infection is the ability of the bacterium to initiate actin tail polymerisation to disseminate into neighbouring cells. Dynamin II is associated with the old pole of the bacteria that is associated with F-actin tail formation. Dynamin II inhibition with dynasore as well as siRNA knockdown significantly reduced Shigella cell to cell spreading in vitro. The ocular mouse Sereny model was used to determine if dynasore could delay the progression of Shigella infection in vivo. While dynasore did not reduce ocular inflammation, it did provide significant protection against weight loss. Therefore dynasore's effects in vivo are unlikely to be related to the inhibition of cell spreading observed in vitro. We found that dynasore decreased S. flexneri-induced HeLa cell death in vitro which may explain the protective effect observed in vivo. These results suggest the administration of dynasore or a similar compound during Shigella infection could be a potential intervention strategy to alleviate disease symptoms.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2013 Lum et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.